Table 4.
Prescription of NSAIDs to patients in each of the two study phases of the educational program n (%)
| Drug therapy |
Phase I |
Phase II |
||
| Before visit | After visit | Before visit | After visit | |
| No NSAID therapy | 718 (41.45) | 162 (9.35) | 653 (37.92) | 190 (11.03) |
| NSAID therapy | 1014 (58.55) | 1570 (90.65) | 1069 (62.08) | 1532 (88.97) |
| Aceclofenac | 146 (8.43) | 248 (14.32)b | 148 (8.59) | 202 (11.73)b |
| Celecoxib | 45 (2.60) | 100 (5.77)b | 35 (2.03) | 116 (6.74)b |
| Diclofenac | 229 (13.22) | 271 (15.65) | 238 (13.82) | 270 (15.68) |
| Etoricoxib | 16 (0.92) | 46 (2.66)b | 18 (1.05) | 79 (4.58)b |
| Ibuprofen | 281 (16.22) | 432 (24.94)b | 297 (17.25) | 406 (23.58)b |
| Indomethacin | 63 (3.64) | 62 (3.58) | 73 (4.24) | 75 (4.36) |
| Ketorolac | 15 (0.87) | 25 (1.44) | 28 (1.63) | 31 (1.80) |
| Meloxicam | 71 (4.10) | 234 (13.51)b | 101 (5.87) | 215 (12.49)b |
| Piroxicam | 74 (4.27) | 75 (4.33) | 64 (3.72) | 64 (3.72) |
| Other NSAIDs includes aproxen) | 19 (1.10) | 22 (1.27) | 16 (0.93) | 28 (1.63) |
| Analgesics | ||||
| Paracetamol | 137 (7.91) | 120 (6.93) | 136 (7.90) | 122 (7.08) |
| Metamizol | 35 (2.02) | 28 (1.62) | 53 (3.08) | 26 (1.51) |
| Total | 1732 (100) | 1722 (100) | ||
b
P < 0.001 vs before the visit.